Drugs / EU sourced Herceptin®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02075073 Comparator | Feb → Apr 2014 | — | Samsung Bioepis Co., Ltd. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EU sourced Herceptin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02075073 ↗ |
| Route | Intravenous | “EU sourced Herceptin®, single dose of 6 mg/kg via intravenous infusion (reference drug)” NCT02075073 ↗ |